Merrion Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Hold
2,975
0.54% 40
2026
Q1
$871K Hold
2,975
0.47% 50
2025
Q4
$1.04M Buy
+2,975
New +$1.01M 0.56% 41

Other funds holding ELV

Merrion Investment Management's ELV Position: Q2 2026 in Review

Merrion Investment Management held its Elevance Health (ELV) position steady in Q2 2026 at 2,975 shares worth $1.15M. The position accounts for 0.54% of the portfolio, ranked #40.

Merrion Investment Management first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 582 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Merrion Investment Management held 2,975 shares of Elevance Health worth $1.15M as of Q2 2026.
  • Merrion Investment Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.54% of Merrion Investment Management's portfolio in Q2 2026, its #40 holding.
  • Merrion Investment Management first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 582 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Merrion Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.